Connect with us

Hi, what are you looking for?


Buy Sunrun shares for a 35% return over the next 12 months: KeyBanc

Sunrun Inc (NASDAQ: RUN) has been a disappointment for its shareholders in recent months but a significant recovery may be in the books over the next twelve months, as per a KeyBanc analyst.

Sunrun shares have upside to $27

On Tuesday, Sophie Karp upgraded the solar stock to “overweight” and said it had upside to $27 – a close to 35% upside from here.

She finds Sunrun shares as attractively valued now that we’re about to see a pause in rate hikes. In her research note, the analyst said:

We acknowledge that [Sunrun] shares have been visibly inexpensive for some time now. However, we’ve seen the worst of tightening cycle, and the sentiment should be bottoming at these levels.

The U.S. Federal Reserve is scheduled for its next meeting in the first week of May.

Sunrun will meet its guidance

Karp is bullish on Sunrun shares also because the alternative energy company has expanded its footprint and is outperforming the industry in California.

The KeyBanc analyst is convinced that the Nasdaq-listed firm will succeed in delivering on its guidance for up to 15% increase in installation capacity this year.

We have a constructive view of RUN’s fundamentals and believe that multiple overhangs created by CA regulatory changes and rate volatility should begin to dissipate in the NT.

Other reasons cited for the constructive view on this solar stock include underappreciated pricing power and potential benefit from the Inflation Reduction Act. Sunrun is expected to lose 11 cents a share this quarter versus 42 cents per share a year ago.

The post Buy Sunrun shares for a 35% return over the next 12 months: KeyBanc appeared first on Invezz.

Enter Your Information Below To Receive Free Trading Ideas, Latest News And Articles.

    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    You May Also Like

    Latest News

    Rep. Jennifer Wexton (D-Va.) announced on Tuesday that she has been diagnosed with Parkinson’s Disease. “If there’s one thing that Democrats and Republicans can...

    Latest News

    After Dianne Feinstein announced she’d contracted the shingles in early March, her staff said she planned to return to the Senate within a matter...


    A U.S. District Court judge has ruled that Elizabeth Holmes, founder and CEO of the disgraced blood-testing company Theranos, cannot remain free on bail...

    Latest News

    SEOUL, South Korea — When a group of American lawmakers arrived in South Korea for meetings with government and military officials, President Yoon Suk-yeol...

    Disclaimer:, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2022 All Rights Reserved.